ADC Therapeutics (NYSE:ADCT – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued on Saturday. A number of other brokerages also recently issued reports on ADCT. Royal Ban…
ADC Therapeutics (NYSE:ADCT) Downgraded to “Sell” Rating by Wall Street Zen
